Innodata Inc. (NASDAQ: INOD) has been identified as a promising, under-the-radar AI stock. The company specializes in preparing and labeling data essential for training large AI models, ensuring high-quality input for optimal AI performance. With a 51% year-to-date increase and an impressive 54% year-over-year growth in Q1, Innodata has also revised its 2026 revenue growth outlook upwards to approximately 40%, signaling strong demand in the AI sector.

Elevance Health, Inc. has demonstrated a significant recovery, with its stock price appreciating by approximately 34% from its lowest point in March. This resurgence is attributed to a broader sector rebound and impressive first-quarter 2026 financial outcomes. The company reported a 1.5% increase in revenue to $49.5 billion and an adjusted EPS growth of 5.1% to $12.58, alongside an improved benefit expense ratio of 86.8%. Based on these positive indicators, Elevance Health has revised its 2026 adjusted EPS forecast upwards to at least $26.75 and anticipates a return to 12% adjusted EPS growth by 2027.

Redwood Trust recently launched RWTS, a 9.75% senior note due in 2031, currently trading just under its face value. Concerns are mounting due to a year-over-year doubling of the company's recourse leverage, now exceeding five times, which raises questions about its capital structure and ability to cover debt. While RWTS offers one of the highest yields among mortgage REIT baby bonds, the increasing leverage and prevailing challenges in the fixed income market suggest a cautious approach. This analysis recommends a 'hold' rating for RWTS given these risk factors.